Tudor Investment Corp
INBX

Tudor Investment Corp’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Tudor Investment Corp’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-18,379
Closed -$698K – 2922
2023
Q4 		$698K Sell
18,379
-3,331
-15% -$71.4K 0.01% 1619
2023
Q3 		$398K Buy
+21,710
New +$454K ﹤0.01% 1783
2022
Q4 		– Sell
-20,358
Closed -$365K – 3055
2022
Q3 		$365K Buy
20,358
+1,467
+8% +$26.4K 0.01% 1639
2022
Q2 		$214K Buy
18,891
+2,941
+18% +$43.3K 0.01% 1776
2022
Q1 		$355K Buy
+15,950
New +$407K 0.01% 1458

Other funds holding INBX

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Tudor Investment Corp's INBX Position: Q1 2024 in Review

Tudor Investment Corp sold out of Inhibrx, Inc. Common Stock (INBX) in Q1 2024, closing a stake of 18,379 shares — an estimated $698K sold.

Tudor Investment Corp first reported a position in INBX in Q1 2022 and held it in 5 quarters. The position peaked at $698K in Q4 2023. 126 funds tracked by Wall St. Rank hold INBX as of Q1 2024.

  • Tudor Investment Corp reported no remaining Inhibrx, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Tudor Investment Corp sold 18,379 Inhibrx, Inc. Common Stock shares in Q1 2024, an estimated $698K.
  • Tudor Investment Corp first reported a position in Inhibrx, Inc. Common Stock in Q1 2022 and held it in 5 quarters.
  • Tudor Investment Corp's Inhibrx, Inc. Common Stock position peaked at $698K in Q4 2023.
  • 126 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q1 2024.

Based on Tudor Investment Corp's 13F filing for Q1 2024, filed 15 May 2024.